CVS HEALTH Corp vs JD.com, Inc., two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVS and JD diverge most: on operating margin, CVS reads 4.7% and JD reads 0.2%; on return on assets, CVS reads 0.4% and JD reads 3.3%. The rest of the comparable metrics sit closer together. What CVS's price implies is a bet that sits within the historical range (whole-company basis). What JD's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVS | JD |
|---|---|---|
| Price | $107.73 | $30.20 |
| Market cap | $137.8B | $45.0B |
| Sector | Retail | Retail |
| Stage | Mature | Mature |
| Implied growth (priced in) | — | +1.0% |
| P/E | — | 16.4 |
| P/B | 1.77 | 1.07 |
| P/S | 0.34 | 0.24 |
| EV/EBITDA | 17.9 | 18.0 |
| Revenue growth | +7.6% | +6.0% |
| Operating margin | 4.7% | 0.2% |
| Net margin | 0.2% | 1.8% |
| Return on equity | 1.3% | 7.9% |
| Return on assets | 0.4% | 3.3% |
| Return on invested capital | 3.2% | 0.7% |
| FCF yield | 5.4% | 3.5% |
| Dividend yield | 2.5% | — |
| Debt / equity | 0.78 | 0.16 |
| Current ratio | 0.87 | 1.22 |
| Altman Z (solvency) | 2.44 | 2.66 |
| Piotroski F (quality) | 6 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.